Browse Products
Technology Platforms
Field of Research
Who We Serve
Discovery
Development
Manufacturing
Enzo Therapeutics
Custom Services
Partnering
Literature & Media
Programs
Help Center
Ordering & Compliance
Company
Account
Region
Thought leadership on technology, venture capital, and building the future.
Showing 1 post
How fluorescence-based screening platforms like FLUOR DE LYS enable high-throughput HDAC inhibitor profiling across enzyme isoforms, accelerating the development of selective epigenetic cancer therapies.
Sign up for exclusive offers, original stories, events and more.